Bright Health Group, Inc.

Bright Health Group, Inc. (BHG)

$9.21

-2.56

(-21.75%)

Live

Insights on Bright Health Group, Inc.

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 1.63B → 502.91M (in $), with an average decrease of 37.5% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -691.17M → -100.34M (in $), with an average increase of 588.8% per quarter

Performance

  • $9.01
    $11.01
    $9.21
    downward going graph

    2.17%

    Downside

    Day's Volatility :18.17%

    Upside

    16.35%

    downward going graph
  • $7.57
    $13,728.00
    $9.21
    downward going graph

    17.81%

    Downside

    52 Weeks Volatility :99.94%

    Upside

    99.93%

    downward going graph

Returns

PeriodBright Health Group, Inc.Sector (Financials)Index (Russel 2000)
3 Months
-83.09%
-10.1%
-6.7%
6 Months
1092.5%
-11.6%
-6.2%
1 Year
592.35%
-9.7%
-6.3%
3 Years
-29.27%
37.2%
26.9%

Highlights

Market Capitalization
93.6M
Book Value
- $42.93
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-67.99
Wall Street Target Price
126.67
Profit Margin
-56.18%
Operating Margin TTM
-15.89%
Return On Assets TTM
-5.01%
Return On Equity TTM
-42.94%
Revenue TTM
2.6B
Revenue Per Share TTM
324.38
Quarterly Revenue Growth YOY
23.3%
Gross Profit TTM
205.8M
EBITDA
-358.6M
Diluted Eps TTM
-67.99
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-33.48
EPS Estimate Next Year
-23.79
EPS Estimate Current Quarter
-0.09
EPS Estimate Next Quarter
-0.07

Analyst Recommendation

Sell
    7%Buy
    35%Hold
    57%Sell
Based on 14 Wall street analysts offering stock ratings for Bright Health Group, Inc.(by analysts ranked 0 to 5 stars)
Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
1
Hold
5
5
7
Sell
8
8
9

Analyst Forecast

What analysts predicted

Upside of 1275.35%

Current $9.21
Target $126.67

Company Financials

FY18Y/Y Change
Revenue
130.6M
-
Net Income
-62.6M
-
Net Profit Margin
-47.95%
-
FY19Y/Y Change
Revenue
280.7M
↑ 114.86%
Net Income
-125.3M
↑ 100.09%
Net Profit Margin
-44.66%
↑ 3.29%
FY20Y/Y Change
Revenue
1.2B
↑ 330.15%
Net Income
-248.4M
↑ 98.22%
Net Profit Margin
-20.58%
↑ 24.08%
FY21Y/Y Change
Revenue
4.0B
↑ 233.75%
Net Income
-1.2B
↑ 374.3%
Net Profit Margin
-29.24%
↓ 8.66%
FY22Y/Y Change
Revenue
2.4B
↓ 40.14%
Net Income
-1.5B
↑ 26.89%
Net Profit Margin
-61.99%
↓ 32.75%
Q4 FY21Q/Q Change
Revenue
962.3M
↓ 10.78%
Net Income
-813.4M
↑ 170.53%
Net Profit Margin
-84.52%
↓ 56.65%
Q1 FY22Q/Q Change
Revenue
1.8B
↑ 90.74%
Net Income
-195.2M
↓ 76.0%
Net Profit Margin
-10.64%
↑ 73.88%
Q2 FY22Q/Q Change
Revenue
1.6B
↓ 14.11%
Net Income
-274.7M
↑ 40.69%
Net Profit Margin
-17.42%
↓ 6.78%
Q3 FY22Q/Q Change
Revenue
1.6B
↑ 3.53%
Net Income
-315.8M
↑ 14.96%
Net Profit Margin
-19.34%
↓ 1.92%
Q4 FY22Q/Q Change
Revenue
551.4M
↓ 66.22%
Net Income
-691.2M
↑ 118.9%
Net Profit Margin
-125.34%
↓ 106.0%
Q1 FY23Q/Q Change
Revenue
502.9M
↓ 8.8%
Net Income
-100.3M
↓ 85.48%
Net Profit Margin
-19.95%
↑ 105.39%
FY19Y/Y Change
Total Assets
820.4M
-
Total Liabilities
1.1B
-
FY20Y/Y Change
Total Assets
1.8B
↑ 120.73%
Total Liabilities
2.3B
↑ 113.57%
FY21Y/Y Change
Total Assets
3.6B
↑ 98.72%
Total Liabilities
2.3B
↑ 0.45%
FY22Y/Y Change
Total Assets
4.7B
↑ 29.64%
Total Liabilities
3.7B
↑ 60.24%
Q4 FY21Q/Q Change
Total Assets
3.6B
↑ 0.65%
Total Liabilities
2.3B
↑ 41.94%
Q1 FY22Q/Q Change
Total Assets
5.3B
↑ 46.6%
Total Liabilities
3.4B
↑ 47.44%
Q2 FY22Q/Q Change
Total Assets
5.3B
↓ 0.26%
Total Liabilities
3.7B
↑ 6.98%
Q3 FY22Q/Q Change
Total Assets
4.6B
↓ 12.33%
Total Liabilities
3.3B
↓ 10.43%
Q4 FY22Q/Q Change
Total Assets
4.7B
↑ 1.15%
Total Liabilities
3.7B
↑ 13.42%
Q1 FY23Q/Q Change
Total Assets
4.8B
↑ 3.92%
Total Liabilities
4.0B
↑ 8.55%
FY18Y/Y Change
Operating Cash Flow
-27.0M
-
Investing Cash Flow
-6.9M
-
Financing Cash Flow
203.1M
-
FY19Y/Y Change
Operating Cash Flow
-8.2M
↓ 69.64%
Investing Cash Flow
-94.6M
↑ 1263.73%
Financing Cash Flow
424.1M
↑ 108.84%
FY20Y/Y Change
Operating Cash Flow
-57.2M
↑ 597.34%
Investing Cash Flow
-689.7M
↑ 628.78%
Financing Cash Flow
712.4M
↑ 68.0%
FY21Y/Y Change
Operating Cash Flow
82.1M
↓ 243.36%
Investing Cash Flow
-552.9M
↓ 19.84%
Financing Cash Flow
1.0B
↑ 46.49%
Q4 FY21Q/Q Change
Operating Cash Flow
-238.0M
↓ 9.86%
Investing Cash Flow
100.2M
↓ 135.18%
Financing Cash Flow
155.8M
↓ 13182.2%
Q1 FY22Q/Q Change
Operating Cash Flow
484.8M
↓ 303.68%
Investing Cash Flow
-633.1M
↓ 731.64%
Financing Cash Flow
592.7M
↑ 280.43%
Q2 FY22Q/Q Change
Operating Cash Flow
241.9M
↓ 50.1%
Investing Cash Flow
-318.5M
↓ 49.7%
Financing Cash Flow
-1.5M
↓ 100.25%
Q3 FY22Q/Q Change
Operating Cash Flow
-614.9M
↓ 354.18%
Investing Cash Flow
488.4M
↓ 253.37%
Financing Cash Flow
304.5M
↓ 20684.92%
Q4 FY22Q/Q Change
Operating Cash Flow
234.5M
↓ 138.14%
Investing Cash Flow
-429.7M
↓ 187.98%
Financing Cash Flow
1.1B
↑ 250.26%

Technicals Summary

Sell

Neutral

Buy

Bright Health Group, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bright Health Group, Inc.
Bright Health Group, Inc.
-8.84%
1092.5%
592.35%
-29.27%
-29.27%
Cigna Corp.
Cigna Corp.
-4.24%
-25.78%
-9.02%
23.22%
40.84%
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
-2.86%
-12.09%
-3.07%
57.4%
96.59%
CVS Health Corporation
CVS Health Corporation
-8.46%
-33.61%
-30.09%
3.05%
2.5%
Humana Inc.
Humana Inc.
-7.2%
-9.69%
9.33%
23.69%
67.56%
  Elevance Health, Inc
Elevance Health, Inc
-5.59%
-16.33%
-5.75%
-5.75%
-5.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bright Health Group, Inc.
Bright Health Group, Inc.
NA
NA
NA
-33.48
-0.43
-0.05
0.0
-42.93
Cigna Corp.
Cigna Corp.
11.19
11.19
1.22
24.69
0.15
0.03
0.02
150.19
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
22.03
22.03
1.66
23.29
0.25
0.07
0.01
87.25
CVS Health Corporation
CVS Health Corporation
22.47
22.47
1.36
8.61
0.05
0.04
0.04
55.81
Humana Inc.
Humana Inc.
20.12
20.12
1.28
28.36
0.19
0.06
0.01
132.67
  Elevance Health, Inc
Elevance Health, Inc
17.3
17.3
1.38
32.85
0.17
0.05
0.01
157.54
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bright Health Group, Inc.
Bright Health Group, Inc.
Sell
$93.6M
-29.27%
NA
-56.18%
Cigna Corp.
Cigna Corp.
Buy
$72.2B
40.84%
11.19
3.69%
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
Buy
$448.3B
96.59%
22.03
6.16%
CVS Health Corporation
CVS Health Corporation
Buy
$86.7B
2.5%
22.47
1.19%
Humana Inc.
Humana Inc.
Buy
$62.0B
67.56%
20.12
3.26%
  Elevance Health, Inc
Elevance Health, Inc
Buy
$105.7B
-5.75%
17.3
3.87%

Institutional Holdings

  • Partners Group Holding AG Junk

    89.18%
  • State Street Corporation

    73.26%
  • Harbourvest Partners, LLC

    53.04%
  • Geode Capital Management, LLC

    49.65%
  • Renaissance Technologies Corp

    46.68%
  • Blackstone Inc

    46.19%

Corporate Announcements

  • Bright Health Group, Inc. Earnings

    Bright Health Group, Inc.’s price-to-earnings ratio stands at None

    Read More

Company Information

Bright Health Group is built upon the belief that by aligning the best local resources in healthcare delivery with the financing of care, the company can drive a superior consumer experience, optimize clinical outcomes, reduce systemic waste and lower costs. Bright Health is a healthcare company that is building a national, integrated system of care, in close partnership with its Care Partners. Its differentiated approach is: Built on Alignment, Focused on the Consumer, and Powered by Technology. Bright Health have two market facing businesses: NeueHealth and Bright HealthCare. Through NeueHealth the company delivers high-quality virtual and in-person clinical care to nearly 75,000 unique patients through its 61 affiliated risk-bearing primary care clinics. Through Bright HealthCare the company offers Medicare and Commercial health plan products to approximately 623,000 consumers in 14 states and 99 markets.

Organization
Bright Health Group, Inc.
Employees
2840
CEO
Mr. George Lawrence Mikan III
Industry
Financial

FAQs